Viemed(VMD) - 2025 Q2 - Quarterly Report

Report Information Viemed Healthcare, Inc. filed its Q2 2025 Form 10-Q, identifying as an accelerated filer with 38.8 million common shares outstanding - Viemed Healthcare, Inc. submitted its Form 10-Q quarterly report for the period ended June 30, 2025[1] - The company's stock ticker is VMD, listed on The Nasdaq Stock Market LLC[3] - The company is designated as an Accelerated Filer[4] - As of July 31, 2025, the company had 38,785,759 common shares outstanding[4] PART I - FINANCIAL INFORMATION This section presents the company's unaudited condensed consolidated financial statements and notes for the periods ended June 30, 2025 and 2024 Item 1. Financial Statements This section includes the company's unaudited condensed consolidated financial statements, comprising balance sheets, income statements, statements of changes in shareholders' equity, and cash flow statements, along with notes for the periods ended June 30, 2025, and 2024 Condensed Consolidated Balance Sheets This statement details the company's financial position, including assets, liabilities, and shareholders' equity, as of specific reporting dates Condensed Consolidated Balance Sheets Key Data (in thousands of dollars) | Metric | June 30, 2025 (Unaudited) | December 31, 2024 (Audited) | Change ($) | Change (%) | | :--------------------------------- | :-------------------------- | :-------------------------- | :--------- | :--------- | | Assets | | | | | | Total current assets | $55,291 | $52,880 | $2,411 | 4.56% | | Total long-term assets | $129,312 | $124,189 | $5,123 | 4.12% | | Total Assets | $184,603 | $177,069 | $7,534 | 4.25% | | Liabilities | | | | | | Total